Nuveen Asset Management »

Peregrine Pharmaceuticals shares owned by Nuveen Asset Management

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Nuveen Asset Management from 13F filings

Historical chart of Nuveen Asset Management investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Nuveen Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Nuveen Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $9.8M 792k 12.35
2024-09-30 $9.0M 791k 11.38
2024-06-30 $1.7M 244k 7.14
2024-03-31 $1.5M 228k 6.70
2023-09-30 $1.6M 165k 9.44
2023-06-30 $2.3M 167k 13.97
2023-03-31 $3.1M 163k 18.76
2022-12-31 $2.3M 170k 13.77
2022-09-30 $3.4M 176k 19.12
2022-06-30 $6.0M 393k 15.26
2022-03-31 $9.7M 446k 21.65
2021-12-31 $17M 672k 24.56
2021-09-30 $18M 849k 20.98
2021-06-30 $24M 942k 25.65
2021-03-31 $19M 1.0M 18.23
2020-12-31 $6.1M 526k 11.54
2020-09-30 $3.0M 394k 7.62
2020-06-30 $2.5M 382k 6.57
2020-03-31 $2.0M 386k 5.11
2019-12-31 $2.2M 283k 7.67
2019-09-30 $1.3M 242k 5.30
2019-06-30 $1.1M 198k 5.60